What's new? Log in Free sign up

Precipio (PRPO) News and press releases

Company Profile

News

From Benzinga Pro

Crude Oil Moves Lower; Carvana Shares Surge

Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets

U.S. stocks traded higher toward the end of trading, with Dow Jones gaining more than 150 points on Thursday. The Dow traded up 0.53% to 33,844.18 while the NASDAQ rose 0.90% to 13,223.26. The S&P 500, also rose, gaining, 0.57% to 4,291.82.

12 Health Care Stocks Moving In Thursday's Intraday Session

Why Oxford Industries Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas

Gainers Baosheng Media Group Holdings Limited (NASDAQ: BAOS) shares climbed 91.2% to $10.81.

Stocks That Hit 52-Week Lows On Thursday

During Thursday, 35 stocks hit new 52-week lows.

Nasdaq Surges Over 100 Points; Signet Jewelers Shares Tumble After Q1 Results

Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets

U.S. stocks traded higher midway through trading, with Nasdaq Composite gaining over 100 points on Thursday. The Dow traded up 0.21% to 33,735.90 while the NASDAQ rose 0.94% to 13,228.32. The S&P 500, also rose, gaining, 0.42% to 4,285.24.

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Precipio, Inc. Announces Pricing Of $2M Registered Direct Offering And Concurrent Private Placement

News, Offerings

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), today announced it has entered into securities purchase agreements with certain institutional investors for the purchase and sale of 4,125,000

Precipio, Inc. Projected Cash Burn Reduced By $1.5M Annually From Three Operational Efficiency Projects

News, Management

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), announces that several operational improvement initiatives which commenced at the start of the year have begun to impact the cash burn and

Precipio's Lab Detects BCR-ABL1 Oncogene Co-Expression Of p190 & p210 Isoforms In A CML Patient By Using HemeScreen Technology

Biotech, News, General

Specialty cancer diagnostics company Precipio, Inc. leveraged its proprietary HemeScreen technology as part of the diagnostic process to monitor a patient with a history of Chronic Myeloid Leukemia (CML) and p210

Precipio Signs Another HemeScreen Customer

News, Contracts

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO) announces another agreement with a new customer to bring HemeScreen™ technology into their laboratory. With each additional

Precipio Granted 180-day Extension From NASDAQ To Regain Compliance

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), announces notification by the NASDAQ Stock Market that the Company has been granted a 180-day extension to allow the Company to meet the required minimum

Earnings Scheduled For April 3, 2023

Companies Reporting Before The Bell • Wejo Gr (NASDAQ:WEJO) is expected to report earnings for its Fiscal Year 2022.

Precipio Earnings Preview

Precipio Ships First IV-Cell Order To Major U.S. Healthcare System

News, Contracts

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO) delivered its first order of IV-Cell®, the Company's proprietary cytogenetics cell culturing media, to a major US healthcare

12 Health Care Stocks Moving In Monday's After-Market Session

Press releases

From Benzinga Pro

Precipio, Inc. Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement

News, Financing, Press Releases

NEW HAVEN, Conn., June 08, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), today announced it has entered into securities purchase agreements with certain institutional

Projected cash burn reduced by $1.5 million annually from Three Operational Efficiency Projects

News, Press Releases

NEW HAVEN, Conn., June 07, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), announces that several operational improvement initiatives which commenced at the start of the year

Precipio's Lab Detects BCR-ABL1 Oncogene Co-Expression of p190 & p210 Isoforms in a CML Patient By Using HemeScreen® Technology

Health Care, Press Releases, General

NEW HAVEN, Conn., May 22, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. leveraged its proprietary HemeScreen technology as part of the diagnostic process to monitor a patient with a

Precipio Shares Growth Catalysts For HemeScreen

Analyst Ratings, Press Releases

NEW HAVEN, Conn., May 17, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), will be discussing on today's shareholders call several growth catalysts that management has been

Precipio Announces Q1-2023 Shareholder Update Call

NEW HAVEN, Conn., May 15, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), will be hosting its Q1-2023 corporate update call on May 17th at 5:00 PM ET. The call will include

Precipio Adds Substantial Pathology Customer to its Diagnostic Services Division

Press Releases, General

NEW HAVEN, Conn., May 04, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO) announces another agreement with a new pathology services customer to utilize Precipio's diagnostic

Precipio Granted 180-day Extension From NASDAQ To Regain Compliance

Markets, Press Releases

NEW HAVEN, Conn., April 27, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), announces notification by the NASDAQ Stock Market that the Company has been granted a 180-day

Precipio Unaudited Q1-2023 Product Revenues Exceed The Two Prior Quarters (Q3+Q4 of 2022) Combined

Press Releases, General

NEW HAVEN, Conn., April 19, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), announces that Q1-2023 product revenues have surpassed product revenues during the two prior

Precipio Announces 2022 Fourth Quarter and Year-End Shareholder Update Call

News, Press Releases

NEW HAVEN, Conn., March 28, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), will be hosting its Q4-2022 and year end shareholder update call on Monday, April 3rd at 5:00 PM

Precipio Ships First IV-Cell® Order to Major US Healthcare System

Health Care, Press Releases

NEW HAVEN, Conn., March 21, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO) delivered its first order of IV-Cell®, the Company's proprietary cytogenetics cell culturing

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.